Developing, optimising, and manufacturing Advanced Therapy Medicinal Products (ATMP鈥檚), such as Cell and Gene Therapy (CGT) products is extremely complex. The choice of a reliable Contract Development Manufacturing Organisation (CDMO) is one of the most critical steps determining your product鈥檚 future.
The global market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services was estimated to be worth US$ 4900 million in 2023 and is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 14.2% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services by region & country, by Type, and by Application.
The Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services.
Market Segmentation
By Company
AGC Biologics
BlueReg
Bio Elpida
Celonic
CGT Catapult
Catalent
Cellipont Bioservices
Lonza
Minaris Regenerative Medicine
Patheon
Rentschler Biopharma SE
Recipeharm
WuXi Advanced Therapies
Segment by Type:
Gene Therapy
Cell Therapy
Tissue Engineered
Others
Segment by Application
Oncology
Cardiology
Central Nervous System
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Introduction
1.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Forecast
1.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Trends & Drivers
1.3.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Industry Trends
1.3.2 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Drivers & Opportunity
1.3.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Challenges
1.3.4 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Players Revenue Ranking (2023)
2.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue by Company (2019-2024)
2.3 Key Companies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services
2.6 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Competitive Analysis
2.6.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Gene Therapy
3.1.2 Cell Therapy
3.1.3 Tissue Engineered
3.1.4 Others
3.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Type
3.2.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, by Type (2019-2030)
3.2.3 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Central Nervous System
4.1.4 Others
4.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Application
4.2.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, by Application (2019-2030)
4.2.3 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Region
5.1.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Region (2019-2024)
5.1.3 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Region (2025-2030)
5.1.4 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
5.2.2 North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
5.3.2 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
5.4.2 Asia Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
5.5.2 South America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value
6.3 United States
6.3.1 United States Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
6.3.2 United States Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
6.4.2 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
6.5.2 China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
6.6.2 Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
6.7.2 South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
6.8.2 Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value, 2019-2030
6.9.2 India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AGC Biologics
7.1.1 AGC Biologics Profile
7.1.2 AGC Biologics Main Business
7.1.3 AGC Biologics Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.1.4 AGC Biologics Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.1.5 AGC Biologics Recent Developments
7.2 BlueReg
7.2.1 BlueReg Profile
7.2.2 BlueReg Main Business
7.2.3 BlueReg Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.2.4 BlueReg Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.2.5 BlueReg Recent Developments
7.3 Bio Elpida
7.3.1 Bio Elpida Profile
7.3.2 Bio Elpida Main Business
7.3.3 Bio Elpida Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.3.4 Bio Elpida Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.3.5 Celonic Recent Developments
7.4 Celonic
7.4.1 Celonic Profile
7.4.2 Celonic Main Business
7.4.3 Celonic Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.4.4 Celonic Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.4.5 Celonic Recent Developments
7.5 CGT Catapult
7.5.1 CGT Catapult Profile
7.5.2 CGT Catapult Main Business
7.5.3 CGT Catapult Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.5.4 CGT Catapult Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.5.5 CGT Catapult Recent Developments
7.6 Catalent
7.6.1 Catalent Profile
7.6.2 Catalent Main Business
7.6.3 Catalent Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.6.4 Catalent Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.6.5 Catalent Recent Developments
7.7 Cellipont Bioservices
7.7.1 Cellipont Bioservices Profile
7.7.2 Cellipont Bioservices Main Business
7.7.3 Cellipont Bioservices Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.7.4 Cellipont Bioservices Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.7.5 Cellipont Bioservices Recent Developments
7.8 Lonza
7.8.1 Lonza Profile
7.8.2 Lonza Main Business
7.8.3 Lonza Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.8.4 Lonza Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.8.5 Lonza Recent Developments
7.9 Minaris Regenerative Medicine
7.9.1 Minaris Regenerative Medicine Profile
7.9.2 Minaris Regenerative Medicine Main Business
7.9.3 Minaris Regenerative Medicine Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.9.4 Minaris Regenerative Medicine Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.9.5 Minaris Regenerative Medicine Recent Developments
7.10 Patheon
7.10.1 Patheon Profile
7.10.2 Patheon Main Business
7.10.3 Patheon Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.10.4 Patheon Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.10.5 Patheon Recent Developments
7.11 Rentschler Biopharma SE
7.11.1 Rentschler Biopharma SE Profile
7.11.2 Rentschler Biopharma SE Main Business
7.11.3 Rentschler Biopharma SE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.11.4 Rentschler Biopharma SE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.11.5 Rentschler Biopharma SE Recent Developments
7.12 Recipeharm
7.12.1 Recipeharm Profile
7.12.2 Recipeharm Main Business
7.12.3 Recipeharm Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.12.4 Recipeharm Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.12.5 Recipeharm Recent Developments
7.13 WuXi Advanced Therapies
7.13.1 WuXi Advanced Therapies Profile
7.13.2 WuXi Advanced Therapies Main Business
7.13.3 WuXi Advanced Therapies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Products, Services and Solutions
7.13.4 WuXi Advanced Therapies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue (US$ Million) & (2019-2024)
7.13.5 WuXi Advanced Therapies Recent Developments
8 Industry Chain Analysis
8.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Industrial Chain
8.2 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Sales Model
8.5.2 Sales Channel
8.5.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
AGC Biologics
BlueReg
Bio Elpida
Celonic
CGT Catapult
Catalent
Cellipont Bioservices
Lonza
Minaris Regenerative Medicine
Patheon
Rentschler Biopharma SE
Recipeharm
WuXi Advanced Therapies
听
听
*If Applicable.
